Ring 1
Ring 2
Ring 3
Ring 4

Tenaya Therapeutics

Financing Rounds

  • Series B
  • Series C
  • Public
Round Led by Symbiosis
Round Led by Symbiosis
Round Led by Symbiosis

Tenaya Therapeutics is a biotechnology company committed to a bold mission: to discover, develop and deliver curative therapies that address the underlying drivers of heart disease. Founded by leading cardiovascular scientists from Gladstone Institutes and the University of Texas Southwestern Medical Center, Tenaya is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine.

tenaya View Website


  • Genetic Medicine
  • Small Molecule


  • Circulatory & Metabolic Disease

Development Status

  • Pre-Clinical

Learn More About Tenaya Therapeutics